RBM39 degrader REC-1245
Term · Oncology and biomedicine · MLC-T-ONC-016378
An orally bioavailable molecular glue degrader of the splicing factor RNA-binding protein 39 (RNA-binding motif protein 39; RBM39), with potential antineoplastic activity. Upon oral administration, RBM39 degrader REC-1245 induces the ubiquitination and proteasome-mediated degradation of RBM39 via the E3 ligase adaptor DCAF15. This modulates RNA splicing, prevents the expression of certain tumor-associated genes, and downregulates DNA damage response (DDR) networks and cell cycle checkpoints including cyclin-dependent kinase 12 (CDK12), which may inhibit tumor cell proliferation. RBM39, overexpressed in many cancers, plays an important role in alternative splicing and regulating the transcription of many tumor-related genes.
| Identifier | MLC-T-ONC-016378 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | RBM39 molecular glue degrader REC-1245 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016378",
"term": "RBM39 degrader REC-1245",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable molecular glue degrader of the splicing factor RNA-binding protein 39 (RNA-binding motif protein 39; RBM39), with potential antineoplastic activity. Upon oral administration, RBM39 degrader REC-1245 induces the ubiquitination and proteasome-mediated degradation of RBM39 via the E3 ligase adaptor DCAF15. This modulates RNA splicing, prevents the expression of certain tumor-associated genes, and downregulates DNA damage response (DDR) networks and cell cycle checkpoints including cyclin-dependent kinase 12 (CDK12), which may inhibit tumor cell proliferation. RBM39, overexpressed in many cancers, plays an important role in alternative splicing and regulating the transcription of many tumor-related genes.",
"synonyms": [
"RBM39 molecular glue degrader REC-1245"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/rbm39-degrader-rec-1245/"
}
Record 14,101 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.